Scienture Holdings, Inc Financials
This page shows Scienture Holdings, Inc (SCNX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 13 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
Scienture Holdings, Inc has an operating margin of -9867.9%, meaning the company retains $-9868 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -10758.7% the prior year.
Scienture Holdings, Inc's revenue surged 215.9% year-over-year to $432K, reflecting rapid business expansion. This strong growth earns a score of 100/100.
Scienture Holdings, Inc carries a low D/E ratio of 0.01, meaning only $0.01 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
Scienture Holdings, Inc's current ratio of 2.89 indicates adequate short-term liquidity, earning a score of 55/100. The company can meet its near-term obligations, though with limited headroom.
While Scienture Holdings, Inc generated -$13.4M in operating cash flow, capex of $12K consumed most of it, leaving -$13.4M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.
Scienture Holdings, Inc generates a -59.2% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from 11.5% the prior year.
Scienture Holdings, Inc passes 5 of 9 financial strength tests. 1 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Scienture Holdings, Inc generates $0.32 in operating cash flow (-$13.4M OCF vs -$41.5M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Scienture Holdings, Inc earns $-300.0 in operating income for every $1 of interest expense (-$42.6M vs $142K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Scienture Holdings, Inc generated $432K in revenue in fiscal year 2025. This represents an increase of 215.9% from the prior year.
Scienture Holdings, Inc's EBITDA was -$42.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 186.4% from the prior year.
Scienture Holdings, Inc reported -$41.5M in net income in fiscal year 2025. This represents a decrease of 557.9% from the prior year.
Scienture Holdings, Inc earned $-2.70 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 208.9% from the prior year.
Cash & Balance Sheet
Scienture Holdings, Inc generated -$13.4M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 6.2% from the prior year.
Scienture Holdings, Inc held $6.7M in cash against $612K in long-term debt as of fiscal year 2025.
Scienture Holdings, Inc had 41M shares outstanding in fiscal year 2025. This represents an increase of 364.3% from the prior year.
Margins & Returns
Scienture Holdings, Inc's gross margin was 76.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 72.4 percentage points from the prior year.
Scienture Holdings, Inc's operating margin was -9867.9% in fiscal year 2025, reflecting core business profitability. This is up 890.8 percentage points from the prior year.
Scienture Holdings, Inc's net profit margin was -9618.0% in fiscal year 2025, showing the share of revenue converted to profit. This is down 16252.7 percentage points from the prior year.
Scienture Holdings, Inc's ROE was -59.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 70.7 percentage points from the prior year.
Capital Allocation
Scienture Holdings, Inc invested $2.0M in research and development in fiscal year 2025. This represents a decrease of 12.5% from the prior year.
Scienture Holdings, Inc invested $12K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 0.0% from the prior year.
SCNX Income Statement
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $590K | N/A | $10K | N/A | $65K+246.9% | $19K | N/A | $112K |
| Cost of Revenue | $15K | N/A | $10K | N/A | $61K+214.3% | $19K | N/A | $243K |
| Gross Profit | $575K | N/A | $673 | N/A | $4K+652.3% | -$703 | N/A | -$131K |
| R&D Expenses | $169K-79.9% | $844K+46.8% | $575K | N/A | $1.3M | N/A | N/A | N/A |
| SG&A Expenses | $2.2M-26.0% | $2.9M+115.9% | $1.4M | N/A | $169K-59.4% | $415K-91.2% | $4.7M+451.8% | $852K |
| Operating Income | -$4.4M+15.4% | -$5.2M-44.4% | -$3.6M | N/A | -$3.5M-133.9% | -$1.5M+72.8% | -$5.5M-146.4% | -$2.2M |
| Interest Expense | $1.8M+176.0% | $653K-2.6% | $671K | N/A | $217K+4293.5% | $5K-95.0% | $99K-86.0% | $703K |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$3.6M+46.3% | -$6.7M-119.3% | -$3.1M | N/A | -$3.2M-73.6% | -$1.8M-108.6% | $21.2M+282.1% | -$11.7M |
| EPS (Diluted) | $-0.19+60.4% | $-0.48-45.5% | $-0.33 | N/A | $-1.34-3.1% | $-1.30-107.8% | $16.77 | N/A |
SCNX Balance Sheet
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $104.8M+0.5% | $104.3M-1.9% | $106.4M+1.4% | $104.9M+11.2% | $94.3M+534.8% | $14.8M-85.8% | $104.9M+736.6% | $12.5M |
| Current Assets | $1.4M+65.9% | $857K-89.1% | $7.8M+24.1% | $6.3M-13.1% | $7.3M-40.3% | $12.1M-13.4% | $14.0M+409.5% | $2.8M |
| Cash & Equivalents | $356K+2211.0% | $15K-99.2% | $2.0M+565.3% | $308K-46.8% | $579K-92.5% | $7.7M+120.6% | $3.5M+969100.0% | $361 |
| Inventory | $235K | N/A | N/A | N/A | $8K+22.4% | $6K+19.9% | $5K+455.0% | $968 |
| Accounts Receivable | $590K | N/A | $4K-66.4% | $11K+6.5% | $10K-20.3% | $13K+88.7% | $7K-18.3% | $8K |
| Goodwill | $21.4M0.0% | $21.4M0.0% | $21.4M0.0% | $21.4M+172.3% | $7.8M | N/A | N/A | N/A |
| Total Liabilities | $22.2M-16.2% | $26.4M+4.9% | $25.2M-2.3% | $25.8M+182.5% | $9.1M+198.0% | $3.1M-96.6% | $91.2M+660.9% | $12.0M |
| Current Liabilities | $7.4M-4.4% | $7.7M+3.0% | $7.5M-5.6% | $7.9M+46.1% | $5.4M+86.5% | $2.9M-1.7% | $3.0M-74.5% | $11.6M |
| Long-Term Debt | $2.0M-44.1% | $3.6M+15.7% | $3.1M+6.7% | $2.9M | N/A | N/A | N/A | N/A |
| Total Equity | $82.7M+6.2% | $77.9M-4.1% | $81.2M+2.6% | $79.1M-7.1% | $85.1M+622.3% | $11.8M-13.5% | $13.6M+2411.1% | $542K |
| Retained Earnings | -$52.4M-7.4% | -$48.8M-16.0% | -$42.1M-7.8% | -$39.0M-22.5% | -$31.9M-20.3% | -$26.5M-7.4% | -$24.7M+25.8% | -$33.2M |
SCNX Cash Flow Statement
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$3.2M-58.0% | -$2.0M+31.2% | -$3.0M-1.6% | -$2.9M+46.0% | -$5.4M-227.6% | $4.2M+141.4% | -$10.2M-899.9% | -$1.0M |
| Capital Expenditures | N/A | N/A | N/A | $0 | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | -$2.9M | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | $0-100.0% | $121K+15730.0% | -$774-100.0% | $27.4M+7937.9% | -$350K |
| Financing Cash Flow | $3.6M | $0-100.0% | $4.7M+68.4% | $2.8M+248.9% | -$1.9M | $0+100.0% | -$13.9M-1140.6% | $1.3M |
| Dividends Paid | N/A | N/A | N/A | $0-100.0% | $2.2M | $0-100.0% | $12.7M | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
SCNX Financial Ratios
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 97.4% | N/A | 6.6% | N/A | 6.0%+9.8pp | -3.8% | N/A | -117.2% |
| Operating Margin | -739.1% | N/A | -34814.9% | N/A | -5392.8%+2606.0pp | -7998.8% | N/A | -1995.4% |
| Net Margin | -611.4% | N/A | -29869.3% | N/A | -4908.3%+4899.2pp | -9807.5% | N/A | -10443.5% |
| Return on Equity | -4.4%+4.3pp | -8.6%-4.9pp | -3.8% | N/A | -3.7%+11.8pp | -15.6%-171.6pp | 156.0%+2306.9pp | -2150.9% |
| Return on Assets | -3.4%+3.0pp | -6.4%-3.6pp | -2.9% | N/A | -3.4%+9.0pp | -12.3%-32.6pp | 20.3%+113.3pp | -93.1% |
| Current Ratio | 0.19+0.1 | 0.11-0.9 | 1.05+0.3 | 0.80-0.5 | 1.34-2.8 | 4.18-0.6 | 4.75+4.5 | 0.24 |
| Debt-to-Equity | 0.02-0.0 | 0.050.0 | 0.040.0 | 0.04-0.1 | 0.11-0.2 | 0.26-6.4 | 6.70-15.4 | 22.11 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Similar Companies
Frequently Asked Questions
What is Scienture Holdings, Inc's annual revenue?
Scienture Holdings, Inc (SCNX) reported $432K in total revenue for fiscal year 2025. This represents a 215.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Scienture Holdings, Inc's revenue growing?
Scienture Holdings, Inc (SCNX) revenue grew by 215.9% year-over-year, from $137K to $432K in fiscal year 2025.
Is Scienture Holdings, Inc profitable?
No, Scienture Holdings, Inc (SCNX) reported a net income of -$41.5M in fiscal year 2025, with a net profit margin of -9618.0%.
What is Scienture Holdings, Inc's EBITDA?
Scienture Holdings, Inc (SCNX) had EBITDA of -$42.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Scienture Holdings, Inc have?
As of fiscal year 2025, Scienture Holdings, Inc (SCNX) had $6.7M in cash and equivalents against $612K in long-term debt.
What is Scienture Holdings, Inc's gross margin?
Scienture Holdings, Inc (SCNX) had a gross margin of 76.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Scienture Holdings, Inc's operating margin?
Scienture Holdings, Inc (SCNX) had an operating margin of -9867.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Scienture Holdings, Inc's net profit margin?
Scienture Holdings, Inc (SCNX) had a net profit margin of -9618.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Scienture Holdings, Inc's return on equity (ROE)?
Scienture Holdings, Inc (SCNX) has a return on equity of -59.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Scienture Holdings, Inc's free cash flow?
Scienture Holdings, Inc (SCNX) generated -$13.4M in free cash flow during fiscal year 2025. This represents a 6.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Scienture Holdings, Inc's operating cash flow?
Scienture Holdings, Inc (SCNX) generated -$13.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Scienture Holdings, Inc's total assets?
Scienture Holdings, Inc (SCNX) had $84.2M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Scienture Holdings, Inc's capital expenditures?
Scienture Holdings, Inc (SCNX) invested $12K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Scienture Holdings, Inc spend on research and development?
Scienture Holdings, Inc (SCNX) invested $2.0M in research and development during fiscal year 2025.
What is Scienture Holdings, Inc's current ratio?
Scienture Holdings, Inc (SCNX) had a current ratio of 2.89 as of fiscal year 2025, which is generally considered healthy.
What is Scienture Holdings, Inc's debt-to-equity ratio?
Scienture Holdings, Inc (SCNX) had a debt-to-equity ratio of 0.01 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Scienture Holdings, Inc's return on assets (ROA)?
Scienture Holdings, Inc (SCNX) had a return on assets of -49.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Scienture Holdings, Inc's cash runway?
Based on fiscal year 2025 data, Scienture Holdings, Inc (SCNX) had $6.7M in cash against an annual operating cash burn of $13.4M. This gives an estimated cash runway of approximately 6 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Scienture Holdings, Inc's Piotroski F-Score?
Scienture Holdings, Inc (SCNX) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Scienture Holdings, Inc's earnings high quality?
Scienture Holdings, Inc (SCNX) has an earnings quality ratio of 0.32x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Scienture Holdings, Inc cover its interest payments?
Scienture Holdings, Inc (SCNX) has an interest coverage ratio of -300.0x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Scienture Holdings, Inc?
Scienture Holdings, Inc (SCNX) scores 43 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.